Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
| $1.02M | ﹤0.01% |
21,361
-950
| -4% | -$48.2K |
|
|
AMT.PRA
2802
DELISTED
American Tower Corporation
AMT.PRA
| $1.02M | ﹤0.01% |
+10,142
| New | +$1.05M |
|
|
TBI
2803
Trueblue
TBI
$311M
| $1.02M | ﹤0.01% |
35,272
-8,404
| -19% | -$237K |
|
2804
CALL
Air Products & Chemicals
APD
$67.6B
| $1.02M | ﹤0.01% |
8,108
-48,536
| -86% | -$6.62M |
|
2805
PUT
Sherwin-Williams
SHW
$89.8B
| $1.02M | ﹤0.01% |
11,100
-26,100
| -70% | -$2.47M |
|
2806
Diodes
DIOD
$4.84B
| $1.02M | ﹤0.01% |
42,367
-9,856
| -19% | -$262K |
|
2807
Federated Hermes
FHI
$4.72B
| $1.02M | ﹤0.01% |
30,767
-3,361
| -10% | -$116K |
|
|
SJI
2808
DELISTED
South Jersey Industries, Inc.
SJI
| $1.01M | ﹤0.01% |
42,344
-22,136
| -34% | -$579K |
|
|
SIVB
2809
PUT
DELISTED
SVB Financial Group
SIVB
| $1.01M | ﹤0.01% |
7,100
+4,700
| +196% | +$635K |
|
|
FL
2810
PUT
DELISTED
Foot Locker
FL
| $1.01M | ﹤0.01% |
15,100
-150,100
| -91% | -$9.36M |
|
|
AFSI
2811
PUT
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $1.01M | ﹤0.01% |
31,000
-50,000
| -62% | -$1.51M |
|
2812
G-III Apparel Group
GIII
$1.5B
| $1.01M | ﹤0.01% |
14,362
+4,542
| +46% | +$278K |
|
2813
MasTec
MTZ
$21.9B
| $1.01M | ﹤0.01% |
52,985
-11,703
| -18% | -$219K |
|
2814
Healthcare Realty
HR
$6.84B
| $1.01M | ﹤0.01% |
43,709
-49,071
| -53% | -$1.25M |
|
|
UPL
2815
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $1M | ﹤0.01% |
83,479
+21,095
| +34% | +$320K |
|
|
TECD
2816
DELISTED
Tech Data Corp
TECD
| $999K | ﹤0.01% |
17,521
-34,432
| -66% | -$2.07M |
|
2817
CALL
Ventas
VTR
$47.9B
| $998K | ﹤0.01% |
14,099
-316,215
| -96% | -$24.7M |
|
|
CDK
2818
DELISTED
CDK Global, Inc.
CDK
| $997K | ﹤0.01% |
18,801
+15,261
| +431% | +$783K |
|
2819
PUT
Canadian Natural Resources
CNQ
$93.8B
| $996K | ﹤0.01% |
76,329
-85,638
| -53% | -$1.29M |
|
|
UMPQ
2820
DELISTED
Umpqua Holdings Corp
UMPQ
| $996K | ﹤0.01% |
58,575
-56,060
| -49% | -$990K |
|
2821
Southern Copper
SCCO
$166B
| $995K | ﹤0.01% |
37,045
-46,843
| -56% | -$1.34M |
|
|
DMND
2822
PUT
DELISTED
DIAMOND FOODS, INC.
DMND
| $995K | ﹤0.01% |
32,100
+30,800
| +2,369% | +$937K |
|
|
WX
2823
CALL
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $995K | ﹤0.01% |
+23,700
| New | +$999K |
|
|
ALE
2824
DELISTED
Allete
ALE
| $990K | ﹤0.01% |
21,545
-12,212
| -36% | -$607K |
|
2825
PUT
Travere Therapeutics
TVTX
$5.78B
| $990K | ﹤0.01% |
+30,000
| New | +$822K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.